GeneDx Holdings Corp. Restructuring Costs
GeneDx Holdings Corp. (WGS) reported Restructuring Costs of $400.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2024-10-29
- GeneDx Holdings Corp. restructuring costs for the quarter ending 2024-09-30 was $400.00K, a 81.82% decline year-over-year.
- GeneDx Holdings Corp. restructuring costs for the quarter ending 2024-06-30 was $200.00K, a 87.50% decline year-over-year.
- GeneDx Holdings Corp. restructuring costs for the quarter ending 2024-03-31 was $800.00K, a 14.29% increase year-over-year.
- GeneDx Holdings Corp. restructuring costs for the quarter ending 2023-09-30 was $2.20M, a 75.53% decline year-over-year.
| Period end | Restructuring Costs 3 month | Restructuring Costs 3 month as first filed | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 9 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | $400.00K 10-Q · filed 2024-10-29 | $600.00K derived: sum of 2 quarters · filed 2024-10-29 | $1.50M 10-Q · filed 2024-10-29 | ||
| 2024-06-30 | $200.00K 10-Q · filed 2024-07-30 | $1.10M 10-Q · filed 2024-07-30 | |||
| 2024-03-31 | $800.00K 10-Q · filed 2024-04-29 | ||||
| 2023-09-30 | $2.20M 10-Q · filed 2024-10-29 | $2.19M 10-Q · filed 2023-11-03 | $3.80M derived: sum of 2 quarters · filed 2024-10-29 | $4.50M 10-Q · filed 2024-10-29 | $4.55M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $1.60M 10-Q · filed 2024-07-30 | $2.30M 10-Q · filed 2024-07-30 | |||
| 2023-03-31 | $700.00K 10-Q · filed 2024-04-29 | ||||
| 2022-09-30 | $8.99M 10-Q · filed 2023-11-03 | $18.55M 10-Q · filed 2023-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |